The Federal Government’s vast expansion the instant asset write-off threshold to $150,000 as part of its coronavirus stimulus package is set to benefit eyecare professionals seeking high value equipment.
Read more
Latest Optovue OCT device arrives in Australia
BOC Instruments has introduced Optovue’s latest optical coherence tomography (OCT) machine to the Australian market, combining numerous ophthalmic diagnostic functions into a single device. Read more
Survey: Device-dependence is altering visual behaviour
One in 10 Australians spend more than 10 hours per day looking at a screen, according to findings of a new Zeiss-commissioned study revealing the extent and risks of device dependence. Read more
Experienced optical mechanic joins newest sunglasses distributor
Sunglass Collective, the latest venture from the team behind Eyes Right Optical, has appointed a new optical mechanic with 30 years’ experience as its head of prescriptions (Rx). Read more
Getting your feet wet in a regional practice
Moving to a rural optometry practice can be rewarding and challenging in equal measure. Specsavers optometrist THUAN TU shares his journey in regional Victoria where he advanced from graduate practitioner to practice manager. Read more
New dry eye therapy now TGA-approved
Australian drug regulators have approved a new aqueous, immunosuppressant for the treatment of moderate-to-severe dry eye. Read more
Novartis pursues PBS listing for Beovu
Novartis is working to ensure its newly-approved drug Beovu is accessible via the Pharmaceutical Benefits Scheme (PBS) at the earliest opportunity after expressing disappointment over an initial decision not to recommend it for the government-subsidised medicines program. Read more
Safilo secures digital position acquisition of Blenders
Italian eyewear group Safilo has sought to galvanise its portfolio of brands, as well as online sales technology, with the acquisition of San Diego-based eyewear manufacturer and retailer Blenders Eyewear. Read more
Anti-inflammatory eye drops added to PBS for Indigenous patients
Prednefrin Forte eye drops can now be prescribed to Aboriginal and Torres Strait Islander patients under the Pharmaceutical Benefits Scheme (PBS) for certain cases of severe eye inflammation. Read more
Zeiss At Lisa tri family IOLs satisfy key performance measures
A meta-analysis of scientific studies evaluating Zeiss’ At Lisa tri family intraocular lenses (IOL) has offered new insight into its performance in terms of patient satisfaction, spectacle independence, visual acuity and predictability. Read more